德國CellGenix   www.cellgenix.com
CellGenix 公司成立于 1994 年，總部設在德國的海德堡。 是一家針對個體定制干細胞和腫瘤免疫療法產品為時常導向的創(chuàng)新生物制藥公司。重點開發(fā)、生產、和銷售有效的用于癌癥治療及組織修復的細胞和蛋白創(chuàng)新產品。
主要特色產品：
CellGro 試劑盒系列 CellGro 干細胞生長培養(yǎng)基
CellGro 細胞因子 CellGro 樹突狀細胞生長培養(yǎng)基

上海微科生化試劑有限公司
Shanghai Weike Biochemical Reagent Co. Ltd. 
Room 1103 International Corporate City, 
No. 3000 North Zhongshan Rd. 
Putuo District 
200063 Shanghai 
China
Phone: +86-21-5271 7801
Fax: +86-21-5271 7239
Email: info@weike21.com
Internet: www.weike21.com

CellGenix Technologie Transfer GmbH is an innovative biopharmaceutical company headquartered in Freiburg, Germany. CellGenix, which was founded in 1994 as a spin-off of the University Medical Center Freiburg, currently has more than 50 employees. CellGenix develops, manufactures and markets cell and protein therapeutics for cancer and orthopedic patients, as well as high-quality reagents for therapeutic ex vivo cell processing. The company owns Metreon Bioproducts GmbH, which was founded in 1996 and which is specialized on cell processing. CellGenix also owns shares in American Fluoroseal Cooperation (Afc) in Gaithersburg, Maryland (USA), and in CellPrep S.A. in Buenos Aires (Argentina).

CellGenix Main Building

View on GMP Facility block

R & D Labs
 
Innovative research and development

Serum-free Chondrocyte Culture
CellGenix's research focuses on stem cell therapy for the regeneration of tissues and organs, cancer immunotherapy and the development of GMP-grade ex vivo cell processing tools, like cytokines, serum-free media and closed kit systems. A patient-specific idiotype vaccine (IdioVax®) against Non-Hodgkin磗 B-cell lymphoma is already in a Phase II clinical trial which is being conducted in collaboration with Freiburg's University Medical Center and the Center for Clinical Research.
 
Cutting edge products and services

High Performance Cytokines
Together with its distribution partners CellGenix markets a variety of superior products and services for clinical cell therapy applications: cord blood cell processing and banking, autologous chondrocyte transplantation as well as GMP-grade cytokines, serum-free media and kit systems for ex vivo cell processing. Additionally, we offer specialized contract manufacturing services. 
 
Safety and superior quality

Quality Control
CellGenix's extensive experience has enabled the company to build up a strong portfolio of products in the field of GMP-compliant production of cell and protein therapeutics. Continuous interaction with various competent authorities assures compliance with highest quality standards in the fields of individual biopharmaceuticals and cell based medicinal products. Since the Fall 2001, with the expansion of its office and production complex near the Freiburg airport, CellGenix has at its disposal one of the most technologically advanced GMP facilities for the processing and manufacturing of individual cell and protein therapeutics.